Chris is an investment professional with a background in healthcare investment banking.
Chris joined the GHO team in 2019 and currently works closely with the Envision Pharma Group and X-Chem management teams, having previously also supported on Linimed.
Prior to GHO, he was with HSBC in London as part of their Healthcare team where he worked on a range of M&A, equity and debt transactions on behalf of both private equity and corporate clients across Europe and Asia.
Chris has a BSc in Mathematics with Economics from The London School of Economics and Political Science (LSE).
Connect with GHO
GHO value creation
Enablement & Alignment
Capability & Capacity
Building Strategic Footprints
Better, faster + more accessible healthcare